FIGURE

Figure 4

ID

ZDB-FIG-230217-51

Publication

Kowald et al., 2023 - Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

Other Figures

All Figure Page

Back to All Figure Page

Figure 4

Tumor dissemination is not significantly impacted by BCG treatment of zebrafish UM-UC-3 tumor xenografts. (A) Cartoon showing the outline of the experiment. Fluorescently labelled UM-UC-3 tumor cells alone or mixed with viable or heat-inactivated BCG were injected into the PVS of 48 h old zebrafish larvae. Alternatively, viable BCG was injected intravenously in subcutaneous tumor-bearing larvae. (B) Fluorescent micrographs of the caudal hematopoietic plexus of control and BCG- (co-)injected tumor-bearing larva at 3 days post-implantation. Red dots represent disseminated tumor cells. (C) Graph showing the quantified number of cells present in the caudal hematopoietic plexus in the different treatment groups. n = 24 injected embryos per group; ns = not significant.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cells